BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 16537705)

  • 1. Interactions of sequence variants in interleukin-1 receptor-associated kinase4 and the toll-like receptor 6-1-10 gene cluster increase prostate cancer risk.
    Sun J; Wiklund F; Hsu FC; Bälter K; Zheng SL; Johansson JE; Chang B; Liu W; Li T; Turner AR; Li L; Li G; Adami HO; Isaacs WB; Xu J; Grönberg H
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):480-5. PubMed ID: 16537705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer.
    Chen YC; Giovannucci E; Kraft P; Lazarus R; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1982-9. PubMed ID: 17932345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
    Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
    J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer.
    Chen YC; Giovannucci E; Lazarus R; Kraft P; Ketkar S; Hunter DJ
    Cancer Res; 2005 Dec; 65(24):11771-8. PubMed ID: 16357190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor heterodimer variants protect from childhood asthma.
    Kormann MS; Depner M; Hartl D; Klopp N; Illig T; Adamski J; Vogelberg C; Weiland SK; von Mutius E; Kabesch M
    J Allergy Clin Immunol; 2008 Jul; 122(1):86-92, 92.e1-8. PubMed ID: 18547625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.
    Hsing AW; Chen C; Chokkalingam AP; Gao YT; Dightman DA; Nguyen HT; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Stanczyk FZ; Reichardt JK
    Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1077-82. PubMed ID: 11588134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variation in the toll-like receptor gene cluster (TLR10-TLR1-TLR6) and prostate cancer risk.
    Stevens VL; Hsing AW; Talbot JT; Zheng SL; Sun J; Chen J; Thun MJ; Xu J; Calle EE; Rodriguez C
    Int J Cancer; 2008 Dec; 123(11):2644-50. PubMed ID: 18752252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation in the Toll-like receptor gene cluster (TLR10-TLR1-TLR6) influences disease course in sarcoidosis.
    Veltkamp M; van Moorsel CH; Rijkers GT; Ruven HJ; Grutters JC
    Tissue Antigens; 2012 Jan; 79(1):25-32. PubMed ID: 22150367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population.
    Suzuki K; Nakazato H; Matsui H; Koike H; Okugi H; Kashiwagi B; Nishii M; Ohtake N; Nakata S; Ito K; Yamanaka H
    Cancer; 2003 Oct; 98(7):1411-6. PubMed ID: 14508827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor 4 genetic variation and advanced prostate cancer risk.
    Cheng I; Plummer SJ; Casey G; Witte JS
    Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):352-5. PubMed ID: 17301271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction of four genes in the inflammation pathway significantly predicts prostate cancer risk.
    Xu J; Lowey J; Wiklund F; Sun J; Lindmark F; Hsu FC; Dimitrov L; Chang B; Turner AR; Liu W; Adami HO; Suh E; Moore JH; Zheng SL; Isaacs WB; Trent JM; Grönberg H
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2563-8. PubMed ID: 16284379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variants in the toll-like receptor signaling pathway and clinical outcomes of malaria.
    Leoratti FM; Farias L; Alves FP; Suarez-Mútis MC; Coura JR; Kalil J; Camargo EP; Moraes SL; Ramasawmy R
    J Infect Dis; 2008 Sep; 198(5):772-80. PubMed ID: 18662133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer.
    Lindmark F; Zheng SL; Wiklund F; Bensen J; Bälter KA; Chang B; Hedelin M; Clark J; Stattin P; Meyers DA; Adami HO; Isaacs W; Grönberg H; Xu J
    J Natl Cancer Inst; 2004 Aug; 96(16):1248-54. PubMed ID: 15316060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic organization and transcript profiling of the bovine toll-like receptor gene cluster TLR6-TLR1-TLR10.
    Opsal MA; Våge DI; Hayes B; Berget I; Lien S
    Gene; 2006 Dec; 384():45-50. PubMed ID: 16950576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A gain of function TGFB1 polymorphism may be associated with late stage prostate cancer.
    Ewart-Toland A; Chan JM; Yuan J; Balmain A; Ma J
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):759-64. PubMed ID: 15159307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor beta polymorphism is associated with prostate cancer risk.
    Thellenberg-Karlsson C; Lindström S; Malmer B; Wiklund F; Augustsson-Bälter K; Adami HO; Stattin P; Nilsson M; Dahlman-Wright K; Gustafsson JA; Grönberg H
    Clin Cancer Res; 2006 Mar; 12(6):1936-41. PubMed ID: 16551880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP1A1 polymorphisms and risk of prostate cancer: a meta-analysis.
    Shaik AP; Jamil K; Das P
    Urol J; 2009; 6(2):78-86. PubMed ID: 19472123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence variants in toll-like receptor 10 are associated with nasopharyngeal carcinoma risk.
    Zhou XX; Jia WH; Shen GP; Qin HD; Yu XJ; Chen LZ; Feng QS; Shugart YY; Zeng YX
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):862-6. PubMed ID: 16702361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of IGFBP3 gene polymorphisms on IGFBP3 serum levels and the risk of prostate cancer in low-risk Korean men.
    Park K; Kim JH; Jeon HG; Byun SS; Lee E
    Urology; 2010 Jun; 75(6):1516.e1-7. PubMed ID: 20350746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.